FIELD: medicine; oncology.
SUBSTANCE: hunger patient takes up Tegafur, dihydropyrimidine dehydrogenase inhibitor and oxonic acid simultaneously.
EFFECT: intensified antineoplastic effect of Tegafur due to higher bioavailability of introduced preparations and reduced gastrointestinal toxicity ensured by higher stability of oxonic acids.
29 cl, 1 tbl, 3 ex
Authors
Dates
2009-03-10—Published
2005-04-27—Filed